Literature DB >> 24144813

Anti-invasive effects of celastrol in hypoxia-induced fibroblast-like synoviocyte through suppressing of HIF-1α/CXCR4 signaling pathway.

Guo-qing Li1, Dan Liu, Yu Zhang, Ya-yun Qian, Yao-dong Zhu, Shi-yu Guo, Masataka Sunagawa, Tadashi Hisamitsu, Yan-qing Liu.   

Abstract

Rheumatoid arthritis (RA) joints are in a hypoxic condition. Hypoxia-induced migration and invasion of fibroblast-like synoviocytes (FLSs) are considered to play a critical role in the pathogenesis of RA. Among the key genes upregulated by hypoxia-inducible factor-1α (HIF-1α), CXC chemokine receptor 4 (CXCR4) plays an important role in FLS migration and invasion. Our previous studies have shown that celastrol exerts anti-arthritic effects by inhibiting FLS migration and invasion under normoxic conditions. However, the effect and molecular mechanisms underlying the effect of celastrol on hypoxia-induced FLS migration and invasion are poorly understood. In the present study, we assessed the effect of celastrol on hypoxia-induced FLS migration and invasion. Results showed that celastrol suppressed hypoxia-induced FLS migration and invasion. In addition, we also found that celastrol inhibited hypoxia-induced CXCR4 expression at both the mRNA and the protein levels in RA-FLSs. Meanwhile, it is revealed that celastrol inhibited the transcriptional activity of CXCR4 under hypoxic conditions by suppressing the binding activity of HIF-1α in the CXCR4 promoter, and blocked hypoxia-induced accumulation of nuclear HIF-1α. Furthermore, treatment with HIF-1α inhibitor reduced the hypoxia-induced expression and transcriptional activity of CXCR4. In conclusion, our results indicate that celastrol inhibits hypoxia-induced migration and invasion via suppression of HIF-1α mediated CXCR4 expression in FLSs under hypoxic conditions. These results provide a strong rationale for further testing and validation of the use of celastrol as a new alternative for using in the treatment of RA.
© 2013.

Entities:  

Keywords:  CXCR4; Celastrol; Fibroblast-like synoviocyte; HIF-1α; Invasion; Rheumatoid arthritis

Mesh:

Substances:

Year:  2013        PMID: 24144813     DOI: 10.1016/j.intimp.2013.10.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  18 in total

1.  Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.

Authors:  Jaewang Lee; Min Park; Min Ho Lee; Hyun Jun Woo; Hyun-Woo Kim; Ji Yeong Yang; Yong-Bin Eom; Sa-Hyun Kim; Changyoung Yoo; Jong-Bae Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 2.  Control of autoimmune inflammation by celastrol, a natural triterpenoid.

Authors:  Shivaprasad H Venkatesha; Steven Dudics; Brian Astry; Kamal D Moudgil
Journal:  Pathog Dis       Date:  2016-07-11       Impact factor: 3.166

3.  Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways.

Authors:  Ya-Yun Qian; Wen-Yuan Li; Yan Yan; Xue-Yu Zhao; Ting Yang; Chuan-Ci Fang; Jing-Jing Hou; Yan-Qing Liu
Journal:  Chin J Integr Med       Date:  2019-05-24       Impact factor: 1.978

4.  Bone-on-a-chip: microfluidic technologies and microphysiologic models of bone tissue.

Authors:  Amin Mansoorifar; Ryan Gordon; Raymond Bergan; Luiz E Bertassoni
Journal:  Adv Funct Mater       Date:  2020-10-25       Impact factor: 19.924

5.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  Celastrol inhibits the proliferation and angiogenesis of high glucose-induced human retinal endothelial cells.

Authors:  Jian Fang; Xiaoke Chang
Journal:  Biomed Eng Online       Date:  2021-06-30       Impact factor: 2.819

7.  Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells.

Authors:  Lin Yang; Yanqing Liu; Mei Wang; Yayun Qian; Xiaojun Dai; Yaodong Zhu; Jue Chen; Shiyu Guo; Tadashi Hisamitsu
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

Review 8.  Hypoxia and its implications in rheumatoid arthritis.

Authors:  Celia María Quiñonez-Flores; Susana Aideé González-Chávez; César Pacheco-Tena
Journal:  J Biomed Sci       Date:  2016-08-22       Impact factor: 8.410

Review 9.  Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias
Journal:  Front Pharmacol       Date:  2016-06-27       Impact factor: 5.810

10.  Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro.

Authors:  Yu-Cong Zou; Xian-Wen Yang; Shi-Guo Yuan; Pei Zhang; Yi-Kai Li
Journal:  Drug Des Devel Ther       Date:  2016-03-07       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.